Windtree Therapeutics is a startup based in the United States.
Windtree Therapeutics is a company headquartered in the United States.
Windtree Therapeutics is a cardiovascular and oncology drug development company (NASDAQ: WINT) whose lead candidate, istaroxime, is a Phase 2 molecule with FDA fast track designation being developed to treat acute heart failure and cardiogenic shock.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.